The Clinical Genetics of Hemophilia B (Factor IX Deficiency)

References

• Castaman G, Matino D. Hemophilia A and B: molecular and clinical similarities and differences. Haematologica. 2019;104(9):1702–1709. doi:10.3324/haematol.2019.221093
   PubMed Web of Science ®Google Scholar
• Choo KH, Gould KG, Rees DJG, Brownlee GG. Molecular cloning of the gene for human anti-haemophilic factor IX. Nature. 1982;299(5879):178–180. doi:10.1038/299178a0
   PubMed Web of Science ®Google Scholar
• Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci USA. 1982;79(21I):6461–6464. doi:10.1073/pnas.79.21.6461
   Web of Science ®Google Scholar
• Rallapalli PM, Kemball-Cook G, Tuddenham EG, Gomez K, Perkins SJ. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B. J Thromb Haemost. 2013;11(7):1329–1340. doi:10.1111/jth.12276
   PubMed Web of Science ®Google Scholar
• Li T, Miller CH, Payne AB, Hooper WC. The CDC Hemophilia B mutation project mutation list: a new online resource. Mol Genet Genomic Med. 2013;1(4):238–245. doi:10.1002/mgg3.30
   PubMedGoogle Scholar
• Rosner F. Hemophilia in the Talmud and rabbinic writings. Ann Intern Med. 1969;70(4):833–837. doi:10.7326/0003-4819-70-4-833
   PubMed Web of Science ®Google Scholar
• Hilgartner MW. Historical Annotation. An account of an hemorrhagic disposition existing in certain families. Haemophilia. 1997;3:154–157. doi:10.1046/j.1365-2516.1997.00050.x
   Web of Science ®Google Scholar
• Biggs R, Douglas AS, Macfarlane RG, et al. Christmas disease: a condition previously mistaken for haemophilia. Br Med J. 1952;2(4799):1378–1382. doi:10.1136/bmj.2.4799.1378
   PubMed Web of Science ®Google Scholar
• Wright IS. Nomenclature of blood clotting factors; acceptance by the International Committee on nomenclature of four factors, their characteristics and international number. Can Med Assoc J. 1958;80(8):659–661.
   Google Scholar
• Rogaev EI, Grigorenko AP, Faskhutdinova G, Kittler ELW, Moliaka YK. Genotype analysis identifies the cause of the “royal disease.” Science. 2009;326(5954):817. doi:10.1126/science.1180660
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Soucie JM, Lusher J, et al. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from the Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project. Haemophilia. 2009;15(6):1281–1290. doi:10.1111/j.1365-2516.2009.02074.x
   PubMed Web of Science ®Google Scholar
• Miller CH, Bean CJ. Genetic causes of haemophilia in women and girls. Haemophilia. 2021;27(2):e164–e179. doi:10.1111/hae.14186
   Web of Science ®Google Scholar
• Kitchen S, de Paula Careta F, de Lima Montalvão SA, et al. Laboratory diagnosis and monitoring. In: Srivastava A, Santagostino E, Dougall A, et al., editors. WFH Guidelines for the Management of Hemophilia, 3rd Edition. Haemophilia; 2020;26(Suppl 6):29–54. doi:10.1111/hae.14046
   Google Scholar
• Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:1935–1939. doi:10.1111/jth.12672
   PubMed Web of Science ®Google Scholar
• Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165–172. doi:10.1182/blood.V70.1.165.165
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544. doi:10.1056/NEJMoa067659
   PubMed Web of Science ®Google Scholar
• Chhabra A, Spurden D, Fogarty PF, et al. Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B. Blood Coagul Fibrinolysis. 2020;31(3):186–192. doi:10.1097/MBC.0000000000000885
   PubMed Web of Science ®Google Scholar
• Iorio A, Fischer K, Blanchette V, et al. Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates. Thromb Haemost. 2017;117(6):1023–1030. doi:10.1160/TH16-12-0942
   PubMed Web of Science ®Google Scholar
• Shapiro AD, Ragni MV, Borhany M, et al. Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural). Haemophilia. 2021;27(1):49–59. doi:10.1111/hae.14139
   Web of Science ®Google Scholar
• Buckner TW, Bocharova I, Hagan K, et al. Health care resource utilization and cost burden of hemophilia B in the United States. Blood Adv. 2021;5(7):1950–1962. doi:10.1182/bloodadvances.2020003424
   Web of Science ®Google Scholar
• Arruda VR, Weber J, Samelson-Jones BJ. Gene therapy for inherited bleeding disorders. Semin Thromb Haemost. 2021;47(2):161–173. doi:10.1055/s-0041-1722862
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Franchini M. Is haemophilia B less severe than haemophilia A? Haemophilia. 2013;19(4):499–502. doi:10.1111/hae.12133
   PubMed Web of Science ®Google Scholar
• Quick AJ, Hussey CV. Hemophilia B (PTC deficiency, or Christmas disease). AMA Arch Intern Med. 1959;103(5):762–775. doi:10.1001/archinte.1959.00270050084014
   Google Scholar
• Soucie JM, Miller CH, Dupervil B, Le B, Buckner TW. Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres. Haemophilia. 2020;26(3):487–493. doi:10.1111/hae.13998
   PubMed Web of Science ®Google Scholar
• Puetz J, Soucie JM, Kempton CL, Monahan PE. Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database. Haemophilia. 2013;20(1):25–31. doi:10.1111/hae.12229
   Web of Science ®Google Scholar
• Warrier I, Ewenstein BM, Koerper MA, et al. Factor IX inhibitors and anaphylaxis in haemophilia B. Haemophilia. 1996;2(4):259–260. doi:10.1111/j.1365-2516.1996.tb00149.x
   Web of Science ®Google Scholar
• Ewenstein BM, Takemoto C, Warrier I, et al. Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood. 1997;89(3):1115–1116. doi:10.1182/blood.V89.3.1115
   PubMed Web of Science ®Google Scholar
• Collins PW, Chalmers E, Hart D, et al. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br J Haematol. 2013;162(6):758–773. doi:10.1111/bjh.12463
   PubMed Web of Science ®Google Scholar
• DiMichele DM, Kroner BL. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost. 2002;87(1):52–57. doi:10.1055/s-0037-1612943
   PubMed Web of Science ®Google Scholar
• Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries. Ann Intern Med. 2019;171(8):542–546. doi:10.7326/M19-1208
   Web of Science ®Google Scholar
• Stonebraker JS, Bolton-Maggs PHB, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia B prevalence around the world. Haemophilia. 2012;18(3):e91–e94. doi:10.1111/j.1365-2516.2011.02588.x
   PubMed Web of Science ®Google Scholar
• Gomez K, Laffan M, Keeney S, Sutherland M, Curry N, Lunt P. Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors’ Organisation Good Practice Paper. Haemophilia. 2019;25(1):116–126. doi:10.1111/hae.13637
   Web of Science ®Google Scholar
• Kasper CK, Lin JC. Prevalence of sporadic and familial haemophilia. Haemophilia. 2007;13(1):90–92. doi:10.1111/j.1365-2516.2006.01397.x
   Web of Science ®Google Scholar
• Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B). Biochemistry. 1985;24(14):3736–3750. doi:10.1021/bi00335a049
   PubMed Web of Science ®Google Scholar
• Roberts HR, Cederbaum AI. The liver and blood coagulation: physiology and pathology. Gastroenterology. 1972;63(2):297–320. doi:10.1016/S0016-5085(19)33318-9
   Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. doi:10.1038/gim.2015.30
   PubMed Web of Science ®Google Scholar
• Briet E, Bertina RM, van Tilburg NH, Veltkamp JJ. Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty. N Engl J Med. 1982;306(13):788–790. doi:10.1056/NEJM198204013061306
   PubMed Web of Science ®Google Scholar
• Ahmed SZ, O’Rourke M, Jenkins V, Regan I, Nolan B. Progressive increase in FIX level in males with haemophilia B Leyden and c.35G>A mutation in early childhood not related to androgen effect. Br J Haematol. 2020;189(6):e262–e265. doi:10.1111/bjh.16688
   Web of Science ®Google Scholar
• Lavin M, Jenkins PV, Healy ML, Byrne M, O’Connell NM, O’Donnell JS. Age-related factor IX correction in symptomatic female carriers with haemophilia B Leyden. Haemophilia. 2015;21(6):e498–e500. doi:10.1111/hae.12761
   Web of Science ®Google Scholar
• DiMichele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A. Severe and moderate haemophilia A and B in US females. Haemophilia. 2014;20(2):e136–e143. doi:10.1111/hae.12364
   Web of Science ®Google Scholar
• Chaudhury A, Sidonio R Jr, Jain N, et al. Women and girls with haemophilia and bleeding tendencies: outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review. Haemophilia. 2021;27(2):293–304. doi:10.1111/hae.14232
   PubMed Web of Science ®Google Scholar
• James PD, Mahlangu J, Bidlingmaier C, et al. Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study. Haemophilia. 2016;22(6):912–918. doi:10.1111/hae.13089
   PubMed Web of Science ®Google Scholar
• Payne AB, Bean CJ, Hooper WC, Miller CH. Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening. J Thromb Haemost. 2012;10(9):1951–1954. doi:10.1111/j.1538-7836.2012.04843.x
   Web of Science ®Google Scholar
• Miller CH, Soucie JM, Byams VR, et al. Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States. Haemophilia. 2021. doi:10.1111/hae.14403
   Web of Science ®Google Scholar
• Karimipoor M, Kokabee L, Kamali E, Karizi SZ, Zeinali S. Molecular analysis of factor IX gene in an Iranian female with severe hemophilia B. Acta Haematol. 2008;119(3):151–153. doi:10.1159/000128043
   Web of Science ®Google Scholar
• Costa JM, Vidaud D, Laurendeau I, et al. Somatic mosaicism and compound heterozygosity in female hemophilia B. Blood. 2000;96(4):1585–1587. doi:10.1182/blood.V96.4.1585.h8001585_1585_1587
   Web of Science ®Google Scholar
• Kelsey G, Monagle P, Barnes C. Delayed diagnosis of congenital factor IX deficiency (Christmas disease) in a girl with Turner’s syndrome. Clin Lab Haematol. 2006;28(5):355–356. doi:10.1111/j.1365-2257.2006.00810.x
   Google Scholar
• Chan DWK, Lam JCM. Young girl with bruising: finding the X factor. J Paediatr Child Health. 2019;55(4):465–467. doi:10.1111/jpc.14282
   Web of Science ®Google Scholar
• Stoof SCM, Kersseboom R, de Vries FAT, Kruip MJHA, Kievit AJA, Leebeek FWG. Hemophilia B in a female with intellectual disability caused by a deletion of Xq26.3q28 encompassing the F9. Mol Genet Genomic Med. 2018;6(6):1220–1224. doi:10.1002/mgg3.425
   Web of Science ®Google Scholar
• Janczar S, Babol-Pokora K, Jatczak-Pawlik I, et al. Puzzling outcome of the nationwide genetic survey of severe/moderate female haemophilia B in Poland. Haemophilia. 2019;25(6):e373–e376. doi:10.1111/hae.13854
   Web of Science ®Google Scholar
• Krepischi-Santos ACV, Carneiro JDA, Svartman M, Bendit I, Odone-Filho V, Vianna-Morgante AM. Deletion of the factor IX gene as a result of translocation t(X;1) in a girl affected by haemophilia B. Br J Haematol. 2001;113(3):616–620. doi:10.1046/j.1365-2141.2001.02786.x
   Web of Science ®Google Scholar
• Sellner LN, Price PJ. Segmental isodisomy and skewed X-inactivation resulting in haemophilia B in a female. Br J Haematol. 2005;131(3):410–411. doi:10.1111/j.1365-2141.2005.05780.x
   PubMed Web of Science ®Google Scholar
• Schröder W, Wulff K, Wollina K, Herrmann FH. Haemophilia B in female twins caused by a point mutation in one factor IX gene and nonrandom inactivation patterns of the X-chromosomes. Thromb Haemost. 1997;78(5):1347–1351. doi:10.1055/s-0038-1665409
   Web of Science ®Google Scholar
• Okumura K, Fujimori Y, Takagi A, et al. Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia B. Haemophilia. 2008;14(5):1088–1093. doi:10.1111/j.1365-2516.2008.01786.x
   Web of Science ®Google Scholar
• Mason JA, Aung HT, Nandini A, et al. Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X-inactivation utilizing case-parent trio SNP microarray analysis. Mol Genet Genomic Med. 2018;6(3):357–369. doi:10.1002/mgg3.378
   Web of Science ®Google Scholar
• Mason JA, Robertson JD. Extreme skewing of X-inactivation: rethinking severe haemophilia in women and girls. Haemophilia. 2019;25(4):e286–e287. doi:10.1111/hae.13755
   Web of Science ®Google Scholar
• Bicocchi MP, Migeon BR, Pasino M, et al. Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A. Eur J Hum Genet. 2005;13(5):635–640. doi:10.1038/sj.ejhg.5201386
   PubMed Web of Science ®Google Scholar
• Haldane JBS. On the rate of spontaneous mutation of a human gene. J Genet. 1935;31:317–326. doi:10.1007/BF02982403
   Google Scholar
• Haldane JB. The mutation rate of the gene for haemophilia, and its segregation ratios in males and females. Ann Eugen. 1947;13(4):262–271. doi:10.1111/j.1469-1809.1946.tb02367.x
   Google Scholar
• Green PM, Saad S, Lewis CM, Giannelli F. Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. Am J Hum Genet. 1999;65(6):1572–1579. doi:10.1086/302651
   Web of Science ®Google Scholar
• Ketterling RP, Vielhaber E, Bottema CDK, et al. Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. Am J Hum Genet. 1993;52(1):152–166.
   PubMed Web of Science ®Google Scholar
• Ketterling RP, Bottema CDK, PhillipsJA III, Sommer SS. Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States. Genomics. 1991;10(4):1093–1096. doi:10.1016/0888-7543(91)90207-U
   Web of Science ®Google Scholar
• Thorland EC, Weinshenker BG, Liu JZ, et al. Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: pattern of mutation and potential founder effects. Thromb Haemost. 1995;74(6):1416–1422. doi:10.1055/s-0038-1649957
   Web of Science ®Google Scholar
• Jenkins VV, Egan H, Keenan C, et al. Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect. Haemophilia. 2008;14(4):717–722. doi:10.1111/j.1365-2516.2008.01765.x
   Web of Science ®Google Scholar
• Ljung R, Petrini P, Tengborn L, Sjörin E. Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity. Br J Haematol. 2001;113(1):81–86. doi:10.1046/j.1365-2141.2001.02759.x
   Web of Science ®Google Scholar
• Knobloch O, Zoll B, Zerres K, Brackmann HH, Olek K, Ludwig M. Recurrent mutations in the factor IX gene: founder effect or repeat de novo events - Investigation of the German haemophilia B population and review of de novo mutations. Hum Genet. 1993;92(1):40–48. doi:10.1007/BF00216143
   Web of Science ®Google Scholar
• Youssoufian H, Pyeritz RE. Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet. 2002;3(10):748–758. doi:10.1038/nrg906
   PubMed Web of Science ®Google Scholar
• Ketterling RP, Vielhaber E, Li X, et al. Germline origins in the human F9 gene: frequent G:C→A:T mosaicism and increased mutations with advanced maternal age. Hum Genet. 1999;105(6):629–640. doi:10.1007/s004390051155
   Web of Science ®Google Scholar
• Cutler JA, Mitchell MJ, Smith MP, Savidge GF. Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiency. Am J Med Genet. 2004;129A(1):13–15. doi:10.1002/ajmg.a.30162
   Web of Science ®Google Scholar
• Kasper CK, Buzin CH. Mosaics and haemophilia. Haemophilia. 2009;15(6):1181–1186. doi:10.1111/j.1365-2516.2009.02003.x
   Web of Science ®Google Scholar
• Taylor SAM, Deugau KV, Lillicrap DP. Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency). Proc Natl Acad Sci USA. 1991;88(1):39–42. doi:10.1073/pnas.88.1.39
   Web of Science ®Google Scholar
• Sommer SS, Knöll A, Greenberg CR, Ketterling RP. Germline mosaicism in a female who seemed to be a carrier by sequence analysis. Hum Mol Genet. 1995;4(11):2181–2182. doi:10.1093/hmg/4.11.2181
   Web of Science ®Google Scholar
• Kim HJ, Lee KO, Yoo KY, Kim SH, Kim HJ. Maternal low-level somatic mosaicism of Cys155Tyr of F9 in severe hemophilia B. Blood Coagul Fibrinolysis. 2015;26(8):866–868. doi:10.1097/MBC.0000000000000234
   Web of Science ®Google Scholar
• Lannoy N, Hermans C. Genetic mosaicism in haemophilia: a practical review to help evaluate the risk of transmitting the disease. Haemophilia. 2020;26(3):375–383. doi:10.1111/hae.13975
   Web of Science ®Google Scholar
• Perez J, Lucena E, Hughes M, Lizcano L, Kasper CK. Preimplantation genetic diagnosis–a historical annotation: first PGD baby turns fifteen. Haemophilia. 2011;17(Suppl 1):18–19. doi:10.1111/j.1365-2516.2011.02560.x
   Web of Science ®Google Scholar
• Peyvandi F, Garagiola I, Mortarino M. Prenatal diagnosis and preimplantation genetic diagnosis: novel technologies and state of the art of PGD in different regions of the world. Haemophilia. 2011;17(Suppl 1):14–17. doi:10.1111/j.1365-2516.2011.02559.x
   PubMed Web of Science ®Google Scholar
• Hudecova I, Jiang P, Davies J, Lo YMD, Kadir RA, Chiu RWK. Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers. Blood. 2017;130(3):340–347. doi:10.1182/blood-2016-12-755017
   Web of Science ®Google Scholar
• Nathwani AC. Gene therapy for hemophilia. Hematology Am Soc Hematol Educ Program. 2019;2019(1):1–8. doi:10.1182/hematology.2019000007
   PubMed Web of Science ®Google Scholar
• Pipe SW. Delivering on the promise of gene therapy for haemophilia. Haemophilia. 2021;27(S3):114–121. doi:10.1111/hae.14027
   PubMed Web of Science ®Google Scholar
• UCL. Factor IX Gene (F9) Variant Database. Available from: http://www.factorix.org/statistics.html.php. Accessed November 07, 2021.
   Google Scholar
• Centers for Disease Control and Prevention. CHBMP F9 Database. Available from: https://www.cdc.gov/ncbddd/hemophilia/champs.html. Accessed October 19, 2021.
   Google Scholar